Trading Options with an Edge
Select Page

RGNX

Search by
TICKER SYMBOL

Regenxbio Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

43.64

0.01

(0.023%)

Volume:

387,518

52 week range:

26.4 - 50.26

Market Cap:

1.859B

Company Description:

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.